MoneyWorks4Me

Natco Pharma gets nod to acquire 0.96% stake in NATCO Pharma Canada Inc.

26 Mar 2021 Evaluate

Natco Pharma has received approval from board to acquire 0.96% stake in NATCO Pharma (Canada) Inc., Post acquisition NATCO Pharma (Canada) Inc., will become wholly owned subsidiary of the company.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

875.25 -8.20 (-0.93%)
25-Aug-2026 09:21 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1901.00
Dr. Reddys Labs. 1187.00
Cipla 1421.00
Lupin 2178.55
Zydus Lifesciences 1101.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: